机构

• 合肥物质科学研究院 [20]
• 深圳先进技术研究院 [10]
• 高能物理研究所 [1]

采集方式

• OAI收割 [30]
• iSwitch采集 [1]

内容类型

• 期刊论文 [30]
• 会议论文 [1]

发表日期

• 2022 [11]
• 2021 [6]
• 2020 [2]
• 2017 [4]
• 2016 [3]
• 2015 [3]
• 更多

学科主题

筛选

浏览/检索结果: 共31条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients 期刊论文  OAI收割 CANCER MEDICINE, 2022 作者:  Hao, Yue;  Lin, Gen;  Xiang, Jing;  Wang, Wenxian;  Xu, Chunwei   |  收藏  |  浏览/下载：31/0  |  提交时间：2022/12/23 efficacy  immune-related adverse events  immunotherapy  thymoma   The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study 期刊论文  OAI收割 CANCER MEDICINE, 2022 作者:  Yu, Xiaoqing;  Si, Jinfei;  Wei, Jingwen;  Wang, Yanling;  Sun, Yan   |  收藏  |  浏览/下载：133/0  |  提交时间：2022/12/23 EGFR-TKIs  non-small cell lung cancer (NSCLC)  real-world study  survival outcome   Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor 期刊论文  OAI收割 THORACIC CANCER, 2022 作者:  Wang, Wenxian;  Wang, Qian;  Xu, Chunwei;  Li, Ziming;  Song, Zhengbo   |  收藏  |  浏览/下载：58/0  |  提交时间：2022/12/23 checkpoint inhibitor pneumonitis  Chinese experts consensus  immune checkpoint inhibitor-related adverse effects   Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study 期刊论文  OAI收割 EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174 作者:  Wang, Wenxian;  Lin, Gen;  Guan, Yelan;  Zhang, Yuxin;  Xu, Chunwei   |  收藏  |  浏览/下载：43/0  |  提交时间：2022/12/23 Thymic carcinoma  Immunotherapy  PD-1  Efficacy  Immune-related adverse events   Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文  OAI收割 THORACIC CANCER, 2022 作者:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo   |  收藏  |  浏览/下载：66/0  |  提交时间：2022/12/22 fusion  precision medicine  solid tumor  targeted therapy  tyrosine receptor kinase   Impact of individualized pharmaceutical care on efficacy and safety of opioid-tolerant outpatients with cancer pain: a multicenter randomized controlled trial 期刊论文  OAI收割 ANNALS OF TRANSLATIONAL MEDICINE, 2022 作者:  Ding, Haiying;  Song, Yu;  Wu, Nan;  Zheng, Xiaowei;  Wei, Qing   |  收藏  |  浏览/下载：55/0  |  提交时间：2022/12/22 Cancer pain  pharmacists  pharmaceutical service  opioids  outpatients   Targeting KRAS mutant cancers: from druggable therapy to drug resistance 期刊论文  OAI收割 MOLECULAR CANCER, 2022, 卷号: 21 作者:  Zhu, Chunxiao;  Guan, Xiaoqing;  Zhang, Xinuo;  Luan, Xin;  Song, Zhengbo   |  收藏  |  浏览/下载：45/0  |  提交时间：2022/12/23 KRAS mutations  Druggable  Resistance  Combination therapy   Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial 期刊论文  OAI收割 BMC MEDICINE, 2022, 卷号: 20 作者:  Song, Zhengbo;  Lou, Guangyuan;  Wang, Yina;  Yang, Zhiping;  Wang, Wenxian   |  收藏  |  浏览/下载：49/0  |  提交时间：2022/12/23 Thymic epithelial tumors  Apatinib  Efficacy  Toxicities   Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study 期刊论文  OAI收割 BMC PULMONARY MEDICINE, 2022, 卷号: 22 作者:  Wang, Wenxian;  Shao, Lan;  Xu, Yibing;  Song, Zhengbo;  Lou, Guangyuan   |  收藏  |  浏览/下载：45/0  |  提交时间：2022/12/23 Non-small cell lung cancer  Prognosis  Angiogenesis  Tyrosine kinase inhibitors   Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study 期刊论文  OAI收割 GENES CHROMOSOMES & CANCER, 2022 作者:  Wang, Wenxian;  Gu, Xiaodong;  Si, Jinfei;  Pu, Xingxiang;  Wang, Liping   |  收藏  |  浏览/下载：88/0  |  提交时间：2022/05/16 BRAF mutation  immune checkpoint inhibitors  non-small cell lung cancer  PD-L1  targeted therapy